Axiologix, Inc. (AXLX: OTC Pink Current) | AXIOLOGIX, INC.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Axiologix, Inc. (AXLX: OTC Pink Current) | AXIOLOGIX, INC. retains leading New York law firm Sichenzia Ross Friedman Ference LLP as SEC counsel and to prepare the Form-10 filing that will allow Axiologix to achieve fully reporting status with the SEC AXIOLOGIX, INC. retains leading New York law firm Sichenzia Ross Friedman Ference LLP as SEC counsel and to prepare the Form-10 filing that will allow Axiologix to achieve fully reporting status with the SEC

AXIOLOGIX, INC. retains leading New York law firm Sichenzia Ross Friedman Ference LLP as SEC counsel and to prepare the Form-10 filing that will allow Axiologix to achieve fully reporting status with the SEC

PR Newswire

ATLANTA , May 27, 2014 /PRNewswire/ -- Axiologix, Inc. (OTC Pinks: AXLX) announced today that it has retained the securities law firm Sichenzia Ross Friedman Ference LLP, located in New York City ( www.SRFF.com ), to represent the Company.

Vincent Browne , Axiologix, Inc.'s CEO said, "Sichenzia Ross Friedman Ference is the premier securities firm for revenue producing microcap companies that plan to grow into major players in their respective markets." Mr. Browne continued, "What attracted us is the depth of talent at SRFF, the fact that we actually interact with the senior partner at a firm of this size, Gregory Sichenzia , and that they have been number one in the "PIPE" (Private Investment in a Public Entity) space over the last 8 plus years."

Gregory Sichenzia, Esq. , Managing Partner of Sichenzia Ross Friedman Ference stated, "We like the Axiologix business plan, its prospects and its management's commitment to doing things the right way. We at SRFF believe that we can support the Company as it continues to grow and look forward to a long-lasting relationship with our new client."

Vincent Browne , concluded, "Given our growth over the past year and our plans to continue that growth in the year ahead, it was time for us to retain a firm of SRFF's stature to assist us with the challenges of that growth. SRFF's first job will be to help us to complete our pending SEC Form 10 filing. We currently anticipate filing the document with the SEC within the next 30 days, which should become effective 60 days after it is filed. This will be another major milestone achieved for the Company and one which should allow us to attract the right kind of investors at more attractive terms going forward."

About Axiologix, Inc.:

Axiologix, Inc. (OTC Pinks: AXLX) based in Atlanta, Georgia , is a public holding company, whose subsidiaries operate in the rapidly growing International Cloud Communications (VOIP) and high margin Mobile Payments/International Remittances markets. For more information please visit our websites at www.axiologix.net , www.axiocomm.net , www.primecarrier.com .

About Sichenzia Ross Friedman Ference LLP

Sichenzia Ross Friedman Ference LLP ("SRFF") provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. Our clients range from start-ups to established, listed companies. They include public and private corporations, partnerships, broker-dealers, investment banks, investment advisors, registered personnel, public and corporate customers and investors, and other entities. We also advise institutional investors on transactions involving complex securities laws. Our practice includes the representation of clients located in the United States and throughout the World. Our areas of expertise include corporate and commercial transactions, mergers and acquisitions, securities litigation and arbitration, administrative practice before regulatory agencies, and broker-dealer regulation. In addition, we provide guidance to Boards of Directors and corporate managers who now operate in an increasingly complex and changing landscape of securities rules, litigation risks, regulatory oversight and investor scrutiny. For more information about our firm please visit our website at: www.srff.com .

Forward Looking Statement Disclaimer:

This press release contains forward-looking statements. Words such as "expects", "intends", "believes", and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

SOURCE Axiologix, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 10

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 11

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 9

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 15

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercury Capital Secures $4.35M Loan for Retail Hub

Updated Category News Views 21

Mercury Capital Partners Banks on Retail Development They say the beauty's in the numbers, but the magic happens when you make those numbers work for you. Mercury Capital Partners (MCP) is wrangling dollars like no one's business, pushing a $4.35 million construction loan into the Fort Myers scene like it's a walk in the park. We're looking at Estero Oaks, a...

Continue Reading
Amazon Analysts Update Forecasts for Upcoming Earnings Report

Updated Category News Views 130

Amazon's Upcoming Earnings Call Amazon.com, Inc. (NASDAQ: AMZN) is set to unveil its earnings results for the second quarter. This announcement will provide valuable insights into the company's financial health and operational performance. Market expectations are leaning toward a positive outlook, as analysts predict robust earnings and revenue growth. Predicted Earnings...

Continue Reading
Understanding the Recent Surge in ServiceNow Options Activity

Updated Category News Views 82

Understanding the Recent Surge in ServiceNow Options Activity Recently, a notable shift occurred in the options market surrounding ServiceNow (NYSE: NOW), drawing attention from both institutional and retail investors. With deep pockets behind these moves, it's crucial to analyze what it could mean for the future of the stock. It’s always intriguing when a significant...

Continue Reading
Join the Exciting Bybit Boost Battle for Weekly USDT Prizes!

Updated Category News Views 176

Join the Exciting Bybit Boost Battle for Weekly USDT Prizes! Bybit, recognized as the second-largest cryptocurrency exchange globally by trading volume, has initiated a vibrant competition called the Boost Battle. This thrilling event allows traders to participate weekly, showcasing their skills and strategies. The grand prize rolls out weekly, presenting winners with the...

Continue Reading
Desert Control's Q2 Progress: Innovations and Financial Insights

Updated Category News Views 190

Desert Control's Q2 2025 Report Summary Desert Control AS (DSRT) has made commendable strides in the second quarter of 2025, revealing significant operational achievements and promising financial results. This report encapsulates the journey and progress of the company, focusing on their innovative solutions that enhance soil health and water conservation. Operational...

Continue Reading